Related Experiment Video
Updated: Aug 11, 2026
16:19
Synthesis, Cellular Delivery and In vivo Application of Dendrimer-based pH Sensors
Published on: September 10, 2013
PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality
István J Majoros1, Andrzej Myc, Thommey Thomas
1Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, 200 Zina Pitcher Place, 4027 Kresge II., Ann Arbor, 48109-0533, USA. majoros@umich.edu
Biomacromolecules
|February 14, 2006
Summary
Researchers developed novel Poly(amidoamine) (PAMAM) dendrimer conjugates for targeted cancer therapy. These multifunctional nanoparticles combine imaging, drug delivery, and targeting agents for enhanced treatment.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Oncology
Background:
- Poly(amidoamine) (PAMAM) dendrimers offer versatile platforms for drug delivery.
- Targeted cancer therapy requires precise delivery of therapeutic and imaging agents.
- Overexpression of folate receptors on cancer cells presents a target for selective drug delivery.
Purpose of the Study:
- To design and synthesize multifunctional PAMAM dendrimer conjugates for targeted cancer therapy.
- To incorporate imaging, targeting, and chemotherapeutic agents into a single nanocarrier.
- To enhance dendrimer solubility and reduce non-specific interactions through surface modification.
Main Methods:
- Synthesis of generation 5 (G5) PAMAM dendrimers with partial surface acetylation.
- Conjugation of fluorescein isothiocyanate (FITC), folic acid (FA), and paclitaxel (Taxol).
- Characterization using gel permeation chromatography (GPC), NMR, potentiometric titration, HPLC, and UV spectroscopy.
Main Results:
- Successfully synthesized and characterized multifunctional G5 PAMAM dendrimer conjugates.
- Modified dendrimers exhibited enhanced solubility and reduced non-specific interactions.
- In vitro studies demonstrated targeted delivery of agents to cancer cells.
Conclusions:
- Multifunctional PAMAM dendrimer conjugates show promise for targeted cancer therapy.
- The developed nanocarriers can simultaneously deliver imaging and chemotherapeutic agents.
- Surface modification strategies improve dendrimer performance for in vitro applications.
